Winner of the Financial Times and McKinsey Business Book of the Year Award
2018You will not want to put this riveting, masterfully reported book
down. No matter how bad you think the Theranos story was, you'll learn that
the reality was actually far worse. Bethany McLean, bestselling coauthor
of The Smartest Guys in the Room and All the Devils Are Here A New York
Times bestseller to be adapted into a film with Jennifer Lawrence to star.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the
female Steve Jobs: a brilliant Stanford dropout whose startup 'unicorn'
promised to revolutionize the medical industry with a machine that would
make blood tests significantly faster and easier. Backed by investors such
as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising
round that valued the company at $9 billion, putting Holmes's worth at an
estimated $4.7 billion. There was just one problem: the technology didn't
work.For years, Holmes had been misleading investors, FDA officials, and
her own employees. When Carreyrou, working at the Wall Street Journal, got
a tip from a former Theranos employee and started asking questions, both
Carreyrou and the Journal were threatened with lawsuits. Undaunted, the
newspaper ran the first of dozens of Theranos' articles in late 2015. By
early 2017, the company's value was zero and Holmes faced potential legal
action from the government and her investors.In Bad Blood John Carreyrou
tells the story of Theranos, and encourages us to consider the possible
repercussions of our blind faith in a small group of brilliant individuals.
PRAISE FOR BAD BLOODA dazzling story of deception in Silicon Valley. . .It
is a tale of heroic cupidity on a scale that made the very best and the
very brightest look like the very, very foolish . . . You will not be able
to put this book down. Washington PostChilling . . . Reads like a West
Coast version of All the President's Men. New York Times Book
ReviewCarreyrou presents the scientific, human, legal and social sides of
the story in full. Although some of it was previously reported in his
extensive coverage, he unveils many dark secrets of Theranos that have not
previously been laid bare. NatureHis [Carreyrou's] unmasking of Theranos
is a tale of David and Goliath. Financial Times